Press release
Global Anti-Depressant Drugs Market Expected to Experience Incremental Growth by 2030, According to DelveInsight | AbbVie, AstraZeneca, Eli Lilly, GlaxoSmithKline, H. Lundbeck AS, Johnson & Johnson, Pfizer, more
Anti-Depressant Drugs Market
DelveInsight's "Anti-Depressant Drugs Market Insights, Competitive Landscape, and Market Forecast - 2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Anti-Depressant Drugs companies actively working in the market.
Request for sample report @ Anti-Depressant Drugs Market - https://www.delveinsight.com/report-store/anti-depressant-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some facts of the Anti-Depressant Drugs Market are:
• As per DelveInsight estimates, North America is anticipated to dominate the global anti-depressant drugs market during the forecast period.
• Notable anti-depressant drugs companies such as AbbVie Inc., AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Organon group of companies, Takeda Pharmaceutical Company Limited, Novartis AG, Biogen Inc., Sage Therapeutics, Axsome Therapeutics, Fabre-Kramer Pharmaceuticals, Inc., Lupin, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Dr Reddy's Laboratories Ltd., and several others, are currently operating in the anti-depressant drugs market.
• In September 2023, the FDA approved a new drug Exxua by Fabre-Kramer Pharmaceuticals to treat major depressive disorder in adults.
• In August 2023, Biogen Inc. and Sage Therapeutics, Inc. announced that the US Food and Drug Administration (FDA) has approved ZURZUVAE™ (zuranolone) 50 mg for adults with postpartum depression (PPD).
• In August 2022, the FDA approved Auvelity which is an extended-release dextromethorphan/bupropion tablet intended for the treatment of major depressive disorder in adults.
Anti-Depressant Drugs Overview
Antidepressant medications are fundamental in treating depression by adjusting neurotransmitter levels in the brain. These drugs, including selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs), help regulate mood-related chemicals to reduce depressive symptoms. For many, antidepressants provide a way to manage the overwhelming effects of depression, improving their overall well-being and restoring a sense of normalcy.
However, the effectiveness of these medications can differ greatly between individuals, often requiring a trial-and-error approach. They may also cause side effects, making close medical supervision essential. Despite these complexities, antidepressants remain crucial in helping millions worldwide cope with depression.
To know more about why North America is leading the market growth in the Anti-Depressant Drugs market, get a snapshot of the report Anti-Depressant Drugs Market Trends - https://www.delveinsight.com/sample-request/anti-depressant-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Anti-Depressant Drugs Market Insights
In 2023, North America dominated the antidepressant drugs market, driven by factors like the growing prevalence of mental health disorders, a strong healthcare system, and continuous advancements in product development. According to the National Institute of Mental Health (NIMH), 52.9 million Americans experienced mental illness in 2020, with 21 million suffering from major depressive episodes, reflecting the high demand for antidepressant medications.
The antidepressants market is expected to expand further between 2024 and 2030, supported by new drug approvals. For instance, in September 2023, Fabre-Kramer Pharmaceuticals gained FDA approval for Exxua, a treatment for major depressive disorder with fewer side effects than existing drugs. This underscores the industry's commitment to developing better, more tolerable treatments.
Globally, mental health disorders, including depression and anxiety, affected 301 million people in 2019, according to the World Health Organization. Ongoing research and clinical trials, such as Autobahn Therapeutics' ABX-002 for major depressive disorder, are poised to drive future market growth.
However, challenges like regulatory requirements, drug safety concerns, and the stigma surrounding mental illness may hinder market expansion. Despite these barriers, North America's strong healthcare infrastructure and innovation make it a key player in the global antidepressant market.
Recent Developments in the Anti-Depressant Drugs Market Report
• In September 2023, the FDA approved a new drug Exxua by Fabre-Kramer Pharmaceuticals to treat major depressive disorder in adults.
• In August 2023, Biogen Inc. and Sage Therapeutics, Inc. announced that the US Food and Drug Administration (FDA) has approved ZURZUVAE™ (zuranolone) 50 mg for adults with postpartum depression (PPD).
To read more about the latest highlights related to Anti-Depressant Drugs, get a snapshot of the key highlights entailed in the Anti-Depressant Drugs Treatment Landscape - https://www.delveinsight.com/report-store/anti-depressant-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Players in the Anti-Depressant Drugs Market
Some of the key market players operating in the Anti-Depressant Drugs market include- AbbVie Inc., AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Organon group of companies, Takeda Pharmaceutical Company Limited, Novartis AG, Biogen Inc., Sage Therapeutics, Axsome Therapeutics, Fabre-Kramer Pharmaceuticals, Inc., Lupin, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Dr Reddy's Laboratories Ltd., among others
Scope of the Anti-Depressant Drugs Market Report
• Coverage: Global
• Study Period: 2021-2030
• Anti-Depressant Drugs Market Segmentation By Drug Type: Selective Serotonin Reuptake Inhibitors (SSRI), Selective-norepinephrine Reuptake Inhibitors (SNRI), Tricyclic Antidepressants (TCA), Monoamine Oxidase Inhibitors (MAOI), and Others
• Anti-Depressant Drugs Market Segmentation By Application: Major Depressive Disorder (MDD), Obsessive-compulsive Disorder (OCD), General Anxiety Disorder (GAD), Panic Disorder (PD), and Others
• Anti-Depressant Drugs Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Anti-Depressant Drugs Companies: AbbVie Inc., AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Organon group of companies, Takeda Pharmaceutical Company Limited, Novartis AG, Biogen Inc., Sage Therapeutics, Axsome Therapeutics, Fabre-Kramer Pharmaceuticals, Inc., Lupin, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Dr Reddy's Laboratories Ltd., among others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Anti-Depressant Drugs KOL - Views and Insights
To keep up with the anti-depressant drugs market trends, we take KOLs and SME's opinions working in the Anti-Depressant Drugs domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging Anti-Depressant Drugs market trends. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Reasons To Buy Anti-Depressant Drugs Market Report:
• The Anti-Depressant Drugs market report will help develop business strategies by understanding the latest trends and changing treatment dynamics driving the Anti-Depressant Drugs Market.
• To understand the existing Anti-Depressant Drugs market opportunity in varying geographies and the growth potential over the coming years.
• Identifying strong upcoming players in the Anti-Depressant Drugs market will help devise strategies that will help get ahead of competitors.
• Detailed analysis and ranking of potential current and emerging therapies under the conjoint analysis section to provide visibility around leading classes.
• To understand the perspective of Key Opinion Leaders around the accessibility, acceptability, and compliance-related challenges of existing treatment to overcome barriers in the future.
• Detailed insights on the unmet needs of the existing Anti-Depressant Drugs market so that the upcoming players can strengthen their development and launch strategy.
Which key players in the Anti-Depressant Drugs market are set to emerge as the trendsetter explore @ Anti-Depressant Drugs Market Landscape - https://www.delveinsight.com/sample-request/anti-depressant-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Anti-Depressant Drugs Market Report Introduction
2. Anti-Depressant Drugs Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Anti-Depressant Drugs Market Key Factors Analysis
6. Anti-Depressant Drugs Market Porter's Five Forces Analysis
7. Anti-Depressant Drugs Market Layout
8. Anti-Depressant Drugs Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
Interested in knowing how the Anti-Depressant Drugs market will grow by 2030? Click to get a snapshot of the Anti-Depressant Drugs Market Forecast- https://www.delveinsight.com/sample-request/anti-depressant-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Central Venous Catheters Market: https://www.delveinsight.com/report-store/central-venous-catheters-market
• Cardiac Resynchronization Therapy Device Market: https://www.delveinsight.com/report-store/cardiac-resynchronization-therapy-market
• Chronic Insomnia Market: https://www.delveinsight.com/report-store/insomnia-market
• Deep Vein Thrombosis Market: https://www.delveinsight.com/report-store/deep-vein-thrombosis-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Hereditary Angioedema Market: https://www.delveinsight.com/report-store/hereditary-angioedema-market
• Hyperhidrosis Market: https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
• Bacterial Skin Diseases Market: https://www.delveinsight.com/report-store/bacterial-skin-diseases-market
• Bile Duct Neoplasm Market: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
• Chronic Lymphocytic Leukemia Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Chronic Obstructive Pulmonary Disease Market: https://www.delveinsight.com/report-store/chronic-obstructive-pulmonary-disease-copd-market
• Hemophilia B Market: https://www.delveinsight.com/report-store/hemophilia-b-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Osteochondromas Market: https://www.delveinsight.com/report-store/osteochondromas-market
• Surgical Stapling Devices Market: https://www.delveinsight.com/report-store/surgical-stapling-devices-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
• 3d Cardiac Mapping System Market: https://www.delveinsight.com/report-store/3d-cardiac-mapping-system-market
• Alopecia Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Burn Market: https://www.delveinsight.com/report-store/burn-market
• Chronic Rhinosinusitis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Chronic Rhinosinustis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Critical Limb Ischemia Market: https://www.delveinsight.com/report-store/critical-limb-ischemia-market
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Progressive Supranuclear Palsy Market: https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market
• Pruritus Market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Alpha Antitrypsin Market: https://www.delveinsight.com/report-store/alpha-1-antitrypsin-deficiency-a1atd-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Epithelioid Sarcoma Market: https://www.delveinsight.com/report-store/epithelioid-sarcoma-market
• Familial Amyloid Polyneuropathy Market: https://www.delveinsight.com/report-store/familial-amyloid-polyneuropathy-transthyretin-amyloidosis-corino-de-andrades-disease-market
• Graft Versus Host Disease Market: https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
• Hemodynamic Monitoring Systems Market: https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/conference-coverage-services
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Anti-Depressant Drugs Market Expected to Experience Incremental Growth by 2030, According to DelveInsight | AbbVie, AstraZeneca, Eli Lilly, GlaxoSmithKline, H. Lundbeck AS, Johnson & Johnson, Pfizer, more here
News-ID: 3685063 • Views: …
More Releases from DelveInsight Business Research
Global Stem Cell Market Size to grow at a CAGR of ~10% by 2030, Evaluates DelveI …
(Albany, USA) As per DelveInsight's assessment, The Stem Cell market is witnessing a positive market growth owing to the factors such as rising prevalence of various chronic diseases and the need for their drug discovery, growing stem cell research activities, and advancements in product development among others.
DelveInsight's "Stem Cell Market Insights, Competitive Landscape, and Market Forecast - 2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges,…
Global Active Pharmaceutical Ingredient Market Size to grow at a CAGR of ~7% by …
(Albany, USA) According to DelveInsight's assessment, the Active Pharmaceutical Ingredient market is projected to experience significant growth in the coming years. This surge is attributed to increasing healthcare expenditures, participation of key companies in the Active Pharmaceutical Ingredient market, and rising applications of Active Pharmaceutical Ingredient. As a result, demand for Active Pharmaceutical Ingredient is anticipated to rise substantially in the near future
DelveInsight's "Active Pharmaceutical Ingredient Market Insights, Competitive Landscape,…
Postoperative Gastrointestinal Dysfunction Clinical Trials 2024: EMA, PDMA, FDA …
(Albany, USA) "Postoperative Gastrointestinal Dysfunction Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Postoperative Gastrointestinal Dysfunction Market.
The Postoperative Gastrointestinal Dysfunction Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the…
Neurotrophic Keratitis Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Ap …
(Albany, USA) DelveInsight's "Neurotrophic Keratitis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Neurotrophic Keratitis, historical and forecasted epidemiology as well as the Neurotrophic Keratitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Neurotrophic Keratitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Neurotrophic Keratitis Market Forecast
https://www.delveinsight.com/sample-request/neurotrophic-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
